Robert Altman, MD, FRCPC
Assistant Professor
MD, FRCPC, CSCN Diplomate (EMG), BSc聽Physical Therapy
Dr. Altman's clinical interests include:
- Education - Teaching in neurology with a strong emphasis on clinical reasoning. Medical school, residency and post-graduate level.
- Advanced general neurology - neurological complications of systemic diseases, including:
- Sarcoidosis
- Neuro-infectious diseases
- Neuro-toxicology
- Neuro-oncology
- Vasculitis
- Complications of rheumatic diseases
- Paraneoplastic syndromes
- Electromyography
- Nerve and muscle diseases
- Headache / craniofacial pain / migraine disorders:
- Greater / lesser occipital nerve blocks.
- Movement disorders
- Parkinson's disease, essential tremor
- Multiple sclerosis and other neuro-inflammatory disorders
1: Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012 Aug 14;79(7):651-8. PubMed PMID: 22855866; PubMed Central PMCID: PMC3414662.
2: Romenets SR, Wolfson C, Galatas C, Pelletier A, Altman R, Wadup L, Postuma RB. Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism
Relat Disord. 2012 Jan;18(1):54-8. PubMed PMID: 21917501.
3: Altman RD, Lang AE, Postuma RB. Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study. Mov Disord. 2011 Nov;26(13):2427-31. PubMed PMID: 21953603.